Latest stories on APVO
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone | APVO Stock News
StockTitan63 · neutralproduct/pr
Aptevo Therapeutics Inc. (APVO) files 8-K
SEC 8-K50 · neutralgeneral
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer | APVO Stock News
StockTitan56 · neutralproduct/pr
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
TipRanks63 · neutralproduct/pr